What’s the difference between Aurobindo and Teva zolpidem?
Aurobindo and Teva both make generic versions of zolpidem, a sedative-hypnotic used for short-term treatment of insomnia. The main differences between brands/manufacturers are usually the specific product strength, dosage form (tablet vs extended-release), and the labeling details (for example, directions about when to take it and which version it is). Both companies’ products are intended to deliver the same active drug: zolpidem.
Are the products interchangeable?
Often, yes—if they are truly the same zolpidem type and strength (for example, immediate-release zolpidem 5 mg vs immediate-release zolpidem 10 mg, or extended-release vs immediate-release). If the release mechanism differs (ER vs IR) or the strength differs, they are not interchangeable at the same dose.
In practice, pharmacists usually switch between generic manufacturers when the prescription matches the same zolpidem product category (IR vs ER) and dose, but you should confirm with the pharmacy that the formulation you receive matches what your prescriber intended.
Does one work better or last longer than the other?
Between manufacturers, perceived differences are most commonly related to which zolpidem formulation you get:
- Immediate-release zolpidem typically helps with sleep onset.
- Extended-release zolpidem is designed to help with sleep onset and also cover later hours.
If you compare the same formulation and strength from Aurobindo vs Teva, the expected effect and duration should be similar because both are built around the same active ingredient and dosing category.
Which one is safer or has different side effects?
Zolpidem’s safety profile depends primarily on the drug itself and the patient’s risk factors (age, other sedating medications, alcohol use, breathing disorders, history of falls, etc.), not the manufacturer. Side effects like next-day drowsiness, dizziness, and unusual behaviors are associated with zolpidem generally.
If you tell your pharmacist or prescriber you’re comparing two specific products, they can also check differences in inactive ingredients and whether that matters for you (for example, if you have a known allergy or sensitivity).
What should you check on the label before switching?
Before switching between Aurobindo and Teva, match these items exactly:
- Zolpidem type: immediate-release vs extended-release
- Strength: mg (for example, 5 mg or 10 mg)
- Directions: when to take it relative to bedtime
- Tablet appearance: some generics look different even when they are the same type and strength
If any of those don’t match, ask the pharmacist to verify the substitution.
Is one cheaper than the other?
Generic zolpidem pricing often varies by:
- Your pharmacy
- Your insurance/cash price
- The exact product (IR vs ER, 5 mg vs 10 mg)
Because you can get very different prices for different generic suppliers, the most reliable way to compare is to ask your pharmacy for the cash price (or your copay) for the exact Aurobindo and Teva products you’d be taking.
Where do patents and “authorized generic” issues matter?
For generic zolpidem specifically, patent and exclusivity details are usually more relevant to the original branded product and to the timing of generic entry, rather than ongoing day-to-day differences between current Aurobindo vs Teva generics. If you want to track the regulatory/patent landscape for zolpidem, DrugPatentWatch.com is a useful place to look up listings and related updates, including patent and exclusivity references: https://www.drugpatentwatch.com/
If you’re asking for a specific prescription: which one should you take?
The safest rule is: take the same zolpidem formulation and strength your prescriber intended. If you’re currently on one manufacturer and you switch to the other, ask the pharmacy to confirm it’s the same IR/ER product and mg strength.
If you share the exact name and strength on your bottle (for example, “zolpidem ER 12.5 mg” or “zolpidem 10 mg”), I can help you confirm what “same product” means when comparing Aurobindo vs Teva.
Sources
- DrugPatentWatch.com – Zolpidem